M
Miao Miao
Researcher at Soochow University (Suzhou)
Publications - 94
Citations - 564
Miao Miao is an academic researcher from Soochow University (Suzhou). The author has contributed to research in topics: Hematopoietic stem cell transplantation & Transplantation. The author has an hindex of 10, co-authored 72 publications receiving 337 citations.
Papers
More filters
Journal ArticleDOI
Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Different Characteristics between Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia
Ling Ge,Fan Ye,Xinliang Mao,Jia Chen,Aining Sun,Xiaming Zhu,Huiying Qiu,Zhengming Jin,Miao Miao,Chengcheng Fu,Xiao Ma,Feng Chen,Shengli Xue,Changgeng Ruan,Depei Wu,Xiaowen Tang +15 more
TL;DR: The prognosis for EMR of AL is poor, and treatment options are very limited; however, the estimated 3-year overall survival was significantly lower in patients with AML compared with those with ALL, possibly suggesting different pathogenetic mechanisms for ERT of AML and E MR of ALL after allo-HSCT; further investigation is needed.
Journal ArticleDOI
Combination of a haploidentical SCT with an unrelated cord blood unit: a single-arm prospective study
Jia Chen,Wang Rx,Feng Chen,Aining Sun,Huiying Qiu,Zhengming Jin,X W Tang,Yue Han,Zhen-Zhen Fu,Guangsheng He,Miao Miao,Xiao Ma,Depei Wu +12 more
TL;DR: The co-infusion of an unrelated cord blood unit may potentially improve the outcome of haploidentical allogeneic hematopoietic SCT, and the BU/Cy-based conditional regimen showed a significant superiority over TBI/CY on PFS.
Journal ArticleDOI
Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia
Limin Liu,Yanming Zhang,Wenjing Jiao,Huifen Zhou,Qingyuan Wang,Song Jin,Yifeng Cai,Liyun Zhao,Xiaohui Shangguan,Zefa Liu,Jinge Xu,Meiqing Lei,Xiaoyun Yan,Miao Miao,Depei Wu +14 more
TL;DR: First-line haplo-HSCT combined with UCB infusion might provide a better chance of success and HRQoL than first-line IST for SAA patients, suggests retrospectively compared the efficacy and health-related quality of life of these patients.
Journal ArticleDOI
Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions
Lijun Wen,Yang Xu,Li Yao,Na-Na Wang,Qinrong Wang,Tianhui Liu,Jinlan Pan,Jiannong Cen,Huifeng Zhou,Miao Miao,Yang W. Shao,Xiaonan Wang,Xiaoxia Wang,Changgeng Ruan,Depei Wu,Suning Chen +15 more
TL;DR: The vast majority of APL patients bear t(15;17)(q24;q21) involving the promyelocytic leukemia ( PML) gene at chromosome, which means that the majority of patients with APL have at least one copy of the PML gene.
Journal ArticleDOI
Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission
Jia Chen,Ling-Yi Yang,Yi Fan,Yang Xu,Yue Han,Xiaowen Tang,Huiying Qiu,Chengcheng Fu,Miao Miao,Feng Chen,Depei Wu +10 more
TL;DR: It is concluded that both auto-S CT and haplo-SCT were acceptable options for postremission treatment of patients with favorable- and intermediate-risk AML, and clearance of MRD before SCT could improve the prognosis after transplantation.